Physician profile
Gregory Devita
NPI 1124103007
$1,117.56
in general payments reported to CMS, 2019-2025
18 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $122 · 2021: $85.51 · 2022: $143 · 2023: $103 · 2024: $154 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $230.24 | 2025 | Novosorb Btm |
| Allergan, INC. | $224.81 | 2019-2022 | |
| Abbvie INC. | $140.82 | 2023-2025 | Alloderm, Botox |
| Apyx Medical Corporation | $73.53 | 2019-2020 | |
| Sientra, INC. | $64.87 | 2022 | |
| Axogen | $52.88 | 2024-2025 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Innovation Technologies INC | $46.81 | 2024 | Irrisept |
| Motiva USA, LLC | $44.95 | 2025 | |
| Integra Lifesciences Corporation | $42.58 | 2020-2021 | |
| Convatec INC. | $29.74 | 2023 | |
| Galderma Laboratories, L.P. | $27.15 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $24.75 | 2024 | |
| Acumed LLC | $23.49 | 2023 | Acumed, Osteomed, Inframe Implant |
| Acelrx Pharmaceuticals, INC. | $23.14 | 2020 | |
| Trevena, INC. | $19.64 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $17.66 | 2025 | Phasix Mesh |
| Mimedx Group, INC. | $16.57 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $13.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Devita listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.